Role of consumer attributes in predicting the impact of medicines deregulation on National Health Service prescribing in the United Kingdom

International Journal of Pharmacy Practice

Volumn 6, Issue 3, 1998, Pages 150-158

  Payne, Katherine ^a   Ryan Woolley, Bernadette M ^a   Noyce, Peter R ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Department of Pharmacy Practice ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; NON PRESCRIPTION DRUG; STEROID;

AEROSOL; ARTICLE; CONSUMER; DECISION MAKING; DEREGULATION; DRUG COST; HEALTH CARE POLICY; HUMAN; NATIONAL HEALTH SERVICE; NORMAL HUMAN; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM;

EID: 0031762428     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.1998.tb00931.x     Document Type: Article

References (23)

1. Herbert C. Self medication expansion not as expected. Pharm J 1994;252:897.
2. Maynard A, Richardson G. Over-the-counter medicines: do they enhance efficiency or cost control? Occasional paper number 13. London: Social Market Foundation, 1996.
3. Thomas DHV, Noyce PR. The interface between self medication and the NHS. BMJ 1996;312:688-91.
4. Government Statistical Service. Statistical Bulletin Number 17. London: HM Stationery Office, 1996.
5. 2 receptor antagonist famotidine to non-prescription status in Canada. An economic evaluation. Pharmacoeconomics 1996;9:61-75.
6. O'Brien, B. The effect of patient charges on the utilization of medicines J Health Econ 1989;8:109-32.
7. Ryan M, Birch S. Evidence on the utilization of NHS prescribed drugs. Soc Sci Med 1991;33:681-87.
8. Huttin C. The use of prescription charges. Health Policy 1994;2:53-73.
9. Schafheutle EI, Cantrill JA, Noyce PR. Insights into the choice between self-medicating and a doctor's prescription: a study of hay fever sufferers. Int J Pharm Pract 1996;4:156-61.
10. Payne K, Ryan-Woolley BM, Noyce PR. Factors influencing consumers to purchase deregulated medicines over the counter. Pharm J 1997:259:R14.
11. Temin P. Costs and benefits of switching drugs from prescription to OTC. J Health Econ 1983;2:187-205.
12. Zadoroznyj M, Svarstad BL. Gender, employment and medication use. Soc Sci Med 1990;31:971-8.
13. Griffin J, editor. Health Information and the Consumer. London: Office of Health Economics, 1996.
14. Ferner RE. Dispensing with prescriptions. BMJ 1994;308:1316.
15. Bissell P, Ward PR, Noyce PR. Variation within community pharmacy. 1. Responding to requests for over-the-counter medicines. J Soc Admin Pharm 1997;14:1-15.
16. Ryan-Woolley BM, Payne K, Noyce PR. The use of deregulated medicines: consumer perspectives. Pharm J 1996;257:R33.
17. Wallston KA, Wallston BS,. DeVellis R. Development of the multidimensional health locus of control. Health Educ Monographs 1978;6:160-70.
18. Russell S, Fox-Rushby J, Arhin D. Willingness and ability to pay for health care: a selection of methods and issues. Health Pol Plan 1995;10:94-101.
19. Baron S, Phillips D. Attitude survey data reduction using CHAID: an example in shopping centre market research. J Market Manage 1994;10:75-88.
20. Tully MP, Temple B. Who are the people who visit and do not visit pharmacies? A descriptive study, using "CHAID". Pharm J 1997;259:R34.
21. Leibowitz A. Substitution between prescribed and over-the-counter medicines. Med Care 1989;27:85-94.
22. Douds AC, Maxwell JD. Over the counter H2 receptor antagonists [letter]. BMJ 1994;309:1156.
23. Choice and Opportunity. Primary Care: the future. Department of Health. London: HM Stationery Office, 1996.